These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 7684069

  • 1. Nicotinic receptor-mediated release of noradrenaline in the human neuroblastoma SH-SY5Y.
    Vaughan PF, Kaye DF, Reeve HL, Ball SG, Peers C.
    J Neurochem; 1993 Jun; 60(6):2159-66. PubMed ID: 7684069
    [Abstract] [Full Text] [Related]

  • 2. Bradykinin-evoked release of [3H]noradrenaline from the human neuroblastoma SH-SY5Y.
    McDonald RL, Kaye DF, Reeve HL, Ball SG, Peers C, Vaughan PF.
    Biochem Pharmacol; 1994 Jul 05; 48(1):23-30. PubMed ID: 8043027
    [Abstract] [Full Text] [Related]

  • 3. The influx of Ca2+ and the release of noradrenaline evoked by the stimulation of presynaptic nicotinic receptors of chick sympathetic neurons in culture are not mediated via L-, N-, or P-type calcium channels.
    Dolezal V, Lee K, Schobert A, Hertting G.
    Brain Res; 1996 Nov 18; 740(1-2):75-80. PubMed ID: 8973800
    [Abstract] [Full Text] [Related]

  • 4. Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells.
    Gould J, Reeve HL, Vaughan PF, Peers C.
    Neurosci Lett; 1992 Oct 12; 145(2):201-4. PubMed ID: 1465217
    [Abstract] [Full Text] [Related]

  • 5. Characterisation of the L- and N-type calcium channels in differentiated SH-SY5Y neuroblastoma cells: calcium imaging and single channel recording.
    Morton AJ, Hammond C, Mason WT, Henderson G.
    Brain Res Mol Brain Res; 1992 Mar 12; 13(1-2):53-61. PubMed ID: 1374505
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia enhances [3H]noradrenaline release evoked by nicotinic receptor activation from the human neuroblastoma SH-SY5Y.
    Wade JA, Vaughan PF, Peers C.
    J Neurochem; 1998 Oct 12; 71(4):1482-9. PubMed ID: 9751181
    [Abstract] [Full Text] [Related]

  • 7. The nicotinic acetylcholine receptor of the bovine chromaffin cell, a new target for dihydropyridines.
    López MG, Fonteríz RI, Gandía L, de la Fuente M, Villarroya M, García-Sancho J, García AG.
    Eur J Pharmacol; 1993 Oct 15; 247(2):199-207. PubMed ID: 7506660
    [Abstract] [Full Text] [Related]

  • 8. Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus.
    Sershen H, Balla A, Lajtha A, Vizi ES.
    Neuroscience; 1997 Mar 15; 77(1):121-30. PubMed ID: 9044380
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.
    McDonald RL, Vaughan PF, Peers C.
    Br J Pharmacol; 1994 Oct 15; 113(2):621-7. PubMed ID: 7834216
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Influence of lobeline on catecholamine release from the isolated perfused rat adrenal gland.
    Lim DY, Kim YS, Miwa S.
    Auton Neurosci; 2004 Jan 30; 110(1):27-35. PubMed ID: 14766322
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of depolarisation-evoked [(3)H]noradrenaline release from SH-SYFY human neuroblastoma cells by muscarinic (M1) receptors is not mediated by changes in [Ca(2+)].
    Roberts DJ, Khan N, McDonald RL, Webster NJ, Peers C, Vaughan PF.
    Brain Res Mol Brain Res; 2001 Feb 19; 87(1):81-91. PubMed ID: 11223162
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of the angiotensin II (AT1A) receptor stably transfected into human neuroblastoma SH-SY5Y cells on noradrenaline release and changes in intracellular calcium.
    McDonald RL, Balmforth AJ, Palmer AC, Ball SG, Peers C, Vaughan PF.
    Neurosci Lett; 1995 Oct 20; 199(2):115-8. PubMed ID: 8584237
    [Abstract] [Full Text] [Related]

  • 19. Distinct effects of omega-toxins and various groups of Ca(2+)-entry inhibitors on nicotinic acetylcholine receptor and Ca2+ channels of chromaffin cells.
    Villarroya M, De la Fuente MT, López MG, Gandía L, García AG.
    Eur J Pharmacol; 1997 Feb 12; 320(2-3):249-57. PubMed ID: 9059861
    [Abstract] [Full Text] [Related]

  • 20. Two types of high voltage-activated calcium channels in SH-SY5Y human neuroblastoma cells.
    Reuveny E, Narahashi T.
    Brain Res; 1993 Feb 12; 603(1):64-73. PubMed ID: 7680940
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.